Rapid Micro Biosystems (RPID) Cost of Revenue (2020 - 2026)

Rapid Micro Biosystems' Cost of Revenue history runs 7 years deep, the most recent figure standing at $7.6 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 12.2% year-over-year to $7.6 million; the TTM figure through Mar 2026 stood at $17.0 million (up 1.05% YoY), while the FY2025 annual figure was $12.1 million, down 8.93% from the prior year.
• Cost of Revenue came in at $7.6 million for Q1 2026 at Rapid Micro Biosystems, up from $3.3 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $7.6 million in Q1 2026 to a low of $2.9 million in Q3 2025.
• A 5-year average of $3.8 million and a median of $3.5 million in 2022 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue decreased 23.35% in 2023 and jumped 107.28% in 2025, its largest moves.
• Rapid Micro Biosystems' Cost of Revenue stood at $4.1 million in 2022, then fell by 23.35% to $3.2 million in 2023, then fell by 5.66% to $3.0 million in 2024, then advanced by 11.4% to $3.3 million in 2025, then surged by 129.71% to $7.6 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $7.6 million, $3.3 million, and $2.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison